Recognition Highlights Inovalon’s Commitment to Delivering High-Quality, Real-World Insights that Drive Life Science Breakthroughs

Inovalon, a leading provider of data and solutions empowering data-driven healthcare, today announced that it has been named the 'Best Analytics Solution Provider of the Year' by BioTech Breakthrough in the 2025 BioTech Breakthrough Awards, in recognition of its Health Economics and Outcomes Research (HEOR) solutions.

“We’re thrilled to recognize Inovalon as the Analytics Solution Provider of the Year for their groundbreaking work in transforming real-world data into actionable insights that drive better access, outcomes, and equity in healthcare,” said Bryan Vaughn, Managing Director of Tech Breakthrough. “Inovalon’s unmatched combination of data depth, scientific expertise, and innovative analytics truly sets them apart as a leader in empowering the biotech industry to meet today’s most urgent challenges with confidence.”

By combining the industry’s largest primary source dataset, advanced analytics, and deep HEOR expertise, Inovalon’s HEOR solutions help life science organizations overcome evidence delays, resource constraints, and payer adoption hurdles. With data spanning all major payer types, including 100% of Medicare FFS, 29% of MA, 31% of commercial, and 89% of Medicaid lives – along with individual-level social drivers of health – Inovalon uniquely delivers a comprehensive view of the patient journey across payer types and the factors that influence treatment access, adherence, utilization, and costs.

“Inovalon’s ability to apply replicable methodology on its comprehensive datasets marks a significant advancement in HEOR analytics – giving policy and decision-makers a true evidence-based understanding of care quality and value,” said Sari Siegel, Ph.D., Senior Vice President, Research, AHIP.

“Being recognized as the ‘Best Analytics Solution Provider of the Year’ underscores our commitment to delivering scientifically rigorous insights that empower HEOR teams to overcome reimbursement challenges, resource constraints, and tight timelines – accelerating confident decision-making,” said Ed Chidsey, President of the Insights business unit at Inovalon.

For more information on Inovalon’s HEOR solutions visit our website: https://www.inovalon.com/products/data-cloud/advanced-analytics-for-health-economics-and-outcomes-research/

About Inovalon

Inovalon is a leading provider of data and solutions empowering data-driven healthcare. The Inovalon ONE^® Platform brings together national-scale connectivity, real-time primary source data access, and advanced analytics into a sophisticated cloud-based platform empowering improved outcomes and economics across the healthcare ecosystem. The company’s analytics and capabilities are used by over 50,000 active, licensed customers, and are informed by the primary source data of more than 93 billion medical events across 1.1 million physicians, 706,000 clinical settings, and 416 million unique lives. For more information, visit www.inovalon.com.

About BioTech Breakthrough

Part of Tech Breakthrough, a leading market intelligence and recognition platform for global technology innovation and leadership, the BioTech Breakthrough Awards program is devoted to honoring excellence in life science and biotechnology solutions, services and companies. The BioTech Breakthrough Awards provide public recognition for the achievements of biotechnology companies and products in categories including BioPharma, Genomics, Therapeutics, Immunology, Food Science and BioAgriculture, and more. For more information visit BioTechBreakthroughAwards.com

Tech Breakthrough LLC does not endorse any vendor, product or service depicted in our recognition programs, and does not advise technology users to select only those vendors with award designations. Tech Breakthrough LLC recognition consists of the opinions of the Tech Breakthrough LLC organization and should not be construed as statements of fact. Tech Breakthrough LLC disclaims all warranties, expressed or implied, with respect to this recognition program, including any warranties of merchantability or fitness for a particular purpose.

View source version on businesswire.com: https://www.businesswire.com/news/home/20251112958298/en/